I can see the commodity price curve

Standing in the crowd, Zhang Yue looked at the volunteers' tired yet proud faces, his eyes slightly reddening.

He strode forward, shook hands with each of the volunteers, and said excitedly:

You guys are amazing!

You have proven the strength of Guoyue Electric Scooter No. 1 with your actions, allowing everyone to see the superior performance of our product!

Media reporters gathered around, their flashes going off one after another.

Zhang Yue took the microphone and confidently said to the camera:

"With this 'Journey of a Thousand Miles' event, Guoyue Electric Vehicle No. 1 responded to all the doubts with practical actions."

It not only boasts powerful battery life but also operates stably in various harsh environments, which fully demonstrates the reliability of our technology and products.

We believe that the Guoyue Electric Scooter No. 1 will become the first choice for consumers' travel!

With the successful conclusion of the event, sales of Guoyue Electric Vehicle No. 1 have ushered in a new round of explosive growth.

Long queues formed again in front of stores, with consumers eager to buy this proven, high-quality electric scooter.

Online discussions about the Guoyue Electric Scooter No. 1 continue to rise, with overwhelmingly positive reviews.

"This electric scooter is simply a miracle!"

It can run from Qingdao to WLMQ without needing to charge along the way—that's amazing!

One netizen excitedly shared this on a social media platform.

"Moreover, its stylish design and powerful performance make it a must-have for going out from now on!"

Another netizen echoed.

At the same time, BYD's electric vehicles are facing an increasingly difficult market situation.

Their sales continued to decline, and their market share was constantly being eroded by Guoyue Electric Vehicle No. 1.

The marketing director of BYD electric vehicles was furious when he saw the dismal sales figures:

"Where did this Guoyue Electric Scooter No. 1 come from? It's stealing our market share!"

The team members kept their heads down, not daring to breathe.

After a long while, an older engineer cautiously said:
"Director, how about we increase our R&D investment and launch a similar product to compete with Guoyue?"

The marketing director glared at him irritably: "Increase R&D? Easier said than done!"

Research and development requires time and money; where do we find the resources right now?
Moreover, even if we launch new products, we might not be able to compete with Guoyue.

Just when BYD electric vehicles were facing difficulties, Zhang Yue was not satisfied with his existing achievements.

He called a meeting with his team members and said, "Although the Guoyue Electric Vehicle No. 1 has achieved great success, we cannot be complacent."

The market is constantly changing, and consumer demands are constantly increasing.

We must continue to increase investment in research and development, constantly improve product performance and quality, and develop more new products that meet market demands.

The team members nodded in agreement. Engineer Li said excitedly:
"Mr. Zhang, we can consider developing a smart electric motorcycle."

We've incorporated more smart technology elements, drawing on our experience in developing self-balancing scooters and electric vehicles.

Features such as autonomous driving assistance, intelligent navigation, and remote monitoring meet consumers' demands for high-end travel.

Zhang Yue's eyes lit up, and he said approvingly, "Engineer Li's idea is excellent!"
The market potential for intelligent electric motorcycles is enormous, and we must seize this opportunity.

Next, everyone must devote themselves fully to the research and development of new products.

Under Zhang Yue's leadership, the technical team sprang into action.

They worked day and night in the laboratory, overcoming one technical challenge after another.

During the development of the autonomous driving assistance system, the team encountered problems such as insufficient sensor accuracy and complex algorithms.

Engineer Li led the R&D team in repeated testing and optimization.

After countless trials and improvements, the accuracy of the sensor was finally improved and the algorithm was optimized.

This enables the autonomous driving assistance system to accurately perceive the surrounding environment and achieve safe and stable driving.

In terms of intelligent navigation, the team collaborated with a professional map provider to develop an intelligent navigation system suitable for electric motorcycles.

This system can not only update traffic information in real time, but also provide personalized navigation route planning based on users' travel habits and preferences.

After more than a year of effort, the intelligent electric motorcycle has finally been successfully developed.

When the first prototype appeared before everyone, everyone was amazed.

Its appearance is stylish and dynamic with smooth lines. The body uses new lightweight materials, which are both sturdy and durable as well as light and flexible.

The front of the vehicle is equipped with a large high-definition display screen that integrates various intelligent functions and is easy and quick to operate.

Zhang Yue personally test-rode the motorcycle, experiencing its powerful performance and convenient operation, and a satisfied smile appeared on his face:

"This is fantastic! This is the kind of future transportation we want."

I believe this intelligent electric motorcycle will once again lead the market trend.

Soon, the intelligent electric motorcycle was officially launched on the market.

At the product launch, Zhang Yue stood on the stage, confidently introducing the new product to the media and consumers:
"This intelligent electric motorcycle is the culmination of our team's hard work, combining the most advanced technology with the most stylish design."

It not only boasts powerful performance and excellent range, but also features a range of intelligent functions such as autonomous driving assistance, intelligent navigation, and remote monitoring.

This will bring you an unprecedented travel experience.

Following the press conference, the intelligent electric motorcycle quickly became a hot topic in the market.

Consumers flocked to various stores, eager to experience the charm of this high-tech product firsthand.

Sales at all stores have been rising steadily, and the influence of the Guoyue brand has been further expanded.

Meanwhile, BYD electric vehicles failed to keep up with market changes and their market share continued to shrink, eventually being gradually eliminated in the fierce market competition.

Standing by the office window, Zhang Yue looked at the bustling city outside and felt a surge of emotions.

He knew that all of this success was inseparable from the team's hard work and perseverance, as well as their spirit of continuous innovation and progress.

Zhan Susu walked over and said with a smile, "What, are you satisfied with this?"

Zhang Yue nodded, then shook his head: "The development of electric vehicles has come to an end."

What do you think I should do next?

Zhan Susu shook her head: "How would I know? Your thoughts are beyond the comprehension of most people."

Zhang Yue laughed and said, "You overestimate me. Many of the things I do are just to make a small contribution to ordinary people."

"Really? In that case, you can go into the medical field."

"The medical industry? Don't I already own Guoyue Pharmaceutical Factory?"

Zhan Susu laughed and said, "Guoyue Pharmaceutical Factory is Guoyue Pharmaceutical Factory, and the medical industry is the medical industry."

Humanity suffers from many diseases, and while many are not fatal, they cause immense pain and suffering.

"Really? For example?"

"For example, uremia."

Zhang Yue frowned slightly, pondered for a moment, and said, "Uremia is indeed a thorny problem, and countless patients suffer from it."

But I don't understand this, what should I do?

"Have you forgotten about your supercomputer?"

Zhang Yue was taken aback: "Using a supercomputer to calculate a treatment for uremia, is that even possible?"

This medical field is completely different from our previous research and development of electric vehicles.

With a firm gaze, Zhan Susu said earnestly, "The power of science and technology is boundless."

Supercomputers have powerful computing capabilities and can analyze massive amounts of medical data, which may provide crucial clues for treating uremia.

Moreover, there are increasingly more cases of medicine and technology combining, so we can definitely give it a try.

Zhang Yue was moved by Zhan Susu's words. He took a deep breath and nodded:

"Okay, since you're so confident, let's give it a try."

I immediately contacted relevant experts and assembled a special team dedicated to using supercomputers to calculate treatment methods for uremia.

Soon, a special team composed of top medical experts, computer scientists, and biologists was established.

The team members worked day and night to collect a large amount of case data, medical research results, and biomolecular information about uremia, and then input this data into the supercomputer.

However, things did not go so smoothly.

In the early stages of the supercomputer's operation, the computer malfunctioned multiple times due to the enormous and complex amount of data, severely hindering the computational progress.

The computer scientists on the team were extremely anxious. They stayed by the computer day and night, constantly debugging the program and optimizing the algorithm.

"This amount of data is too large; the computer simply can't process it. If this continues, when will we ever get any results?"

"I can't believe it," a young computer scientist said anxiously.

The team leader frowned and comforted them, "Don't worry, everyone check the program again carefully and see if we can find a way to optimize it."

We must overcome this difficulty.

After several days and nights of hard work, computer scientists finally found the key to the problem and made significant optimizations to the program.

The supercomputer resumed high-speed operation, and this time, the computation progress was significantly faster.

But new challenges emerged one after another.

When analyzing the results, medical experts found that the data presented an extremely complex and difficult-to-understand pattern, making it impossible to directly derive effective treatment methods from it.

"These data are too chaotic; there is absolutely no pattern to them."

"How can we find a way to treat uremia?" a medical expert said, shaking his head helplessly.

The team fell into a brief silence; everyone felt somewhat frustrated.

At this moment, a biologist suddenly had a flash of inspiration and said, "Could we look at this problem from a different angle?"
Perhaps behind these seemingly chaotic data lies some special biological mechanism.

We can reanalyze this data from a biological perspective.

Everyone who listened to the biologist thought it made a lot of sense.

Therefore, the team members readjusted their approach and conducted an in-depth analysis of the data from a biological perspective.

After countless discussions and attempts, they finally derived three special formulas after the supercomputer had been running for nearly a month.

Upon hearing the news, Zhang Yue was overjoyed and immediately rushed to the laboratory where his team was located.

"Thank you all for your hard work! I heard we've made a major breakthrough. Tell me about these three formulas."

The team leader excitedly introduced, "Mr. Zhang, these three formulas are derived from our analysis and calculation of massive amounts of data."

These respectively involve the metabolic mechanisms of toxins in uremia patients, the repair mechanisms of kidney cells, and the regulatory mechanisms of the immune system.

We believe that these three formulas will provide crucial theoretical support for the treatment of uremia.

After listening carefully to the introduction, Zhang Yue's eyes shone with hope.

He said decisively, "Great! That's fantastic."

Next, I immediately assembled a professional research and development team to develop drugs and therapies for treating uremia based on these three formulas.

Your team should continue to provide technical support to ensure the smooth progress of the research and development work.

A new research and development team was quickly formed, and they began intensive work on drug development and therapy exploration based on three special formulas.

However, the research and development process was not without its challenges.

During the drug synthesis stage, researchers found that drugs synthesized according to the formula were highly effective in the laboratory environment, but caused serious side effects in animal experiments.

"What's going on? This shouldn't happen when synthesizing drugs according to the formula," a researcher said anxiously.

The head of the R&D team calmly analyzed, "Don't panic, everyone. There's nothing wrong with the formula itself."

It's possible that there were some deviations in our drug synthesis process, or that there were some interfering factors in the animal experiment environment.

We re-examined the synthesis steps, adjusted the experimental conditions, and tried again.

After repeated trials and adjustments, the researchers finally found the problem and successfully synthesized a drug without side effects.

Next, the team encountered new challenges in exploring treatments.

How to accurately deliver drugs to the patient's kidneys to achieve the best therapeutic effect has become a key problem they need to overcome.

"If the drug cannot reach the kidneys accurately, the treatment effect will be greatly reduced. We must find an effective drug delivery method," said the head of the research and development team.

The team members began to consult a large amount of information and try various methods.

After countless failures, a young researcher proposed a bold idea:

“We can use nanotechnology to encapsulate drugs in nanoparticles, and then guide the nanoparticles to the kidneys through specific targeting molecules.”

Everyone thought the idea was very creative.

Therefore, the team immediately began developing a nanomedicine delivery system.

After a period of effort, they finally succeeded in developing a nanomedicine delivery system that can accurately deliver drugs to the kidneys.

Upon learning that the R&D team had successfully overcome the challenge, Zhang Yue immediately convened a meeting with relevant personnel, his expression serious yet expectant.

"Now that the drugs and delivery systems are ready, clinical trials are the crucial step."

We must recruit enough volunteers as soon as possible so that uremia patients can benefit from them sooner.

Manager Li, who was in charge of recruiting volunteers, looked troubled and hesitated before saying:

"Mr. Zhang, there is a tricky problem right now."

Miaoshou Group is also conducting clinical trials related to the treatment of uremia. With its long-standing reputation and extensive network in the medical field, it has attracted a large number of volunteers.

Many patients and their families are more willing to trust them, so our recruitment efforts are progressing very slowly.

Zhang Yue frowned, pondered for a moment, and then said, "We cannot sit idly by and wait for our doom."

In this way, we should first increase publicity efforts, explaining the principles, processes, and current achievements of our research and development.

We will announce this to the public through multiple channels, allowing everyone to understand our sincerity and capabilities.

Manager Li shook his head helplessly: "We've done a lot of advertising, but the results haven't been ideal."

Miaoshou Group is also promoting it heavily, and they've offered many preferential terms.

For example, providing free follow-up treatment to volunteers makes it even harder for us to recruit people.

Zhang Yue stood up and paced back and forth in the conference room. Suddenly, he stopped and said:
"We can't just focus on propaganda."

In this way, we personally went to the hospital to communicate with uremia patients and their families, trying to move them with our sincerity.

So Zhang Yue led his team to a large local hospital.

They set up promotional display boards in the hospital corridors and distributed informational materials to passing patients and their families.

Zhang Yue personally walked up to a middle-aged man sitting on a bench, looking dejected, squatted down, and whispered:
"Brother, I know that you or your family members are suffering from uremia."

Our Guoyue Group has developed a drug and therapy that may treat uremia.

We are currently recruiting volunteers for clinical trials. Would you like to learn more?

The middle-aged man looked up, his eyes filled with suspicion and wariness:

"Your Guoyue Group?"
I've never heard of you doing medical research. I still trust Miaoshou Group more; they're a big brand.

Zhang Yue was not discouraged and patiently explained, "Brother, although we mainly developed in other fields before, this time we have invested a lot of manpower, material resources and financial resources to overcome the problem of uremia."

Our R&D team consists of top experts, and our methods are based on scientific evidence.

"Look, these are our research and development materials and experimental data." As he spoke, Zhang Yue handed over a detailed document.

The middle-aged man took the documents, flipped through a few pages casually, and then shook his head.
"I'm still a little worried. What if something goes wrong? Miaoshou Group has promised to provide free follow-up treatment."

At this moment, a young woman next to her chimed in, "That's right, what guarantees can you give us?"

"Miracle Hands Group is so famous, we naturally prefer to choose them."

Zhang Yue stood up and said sincerely, "We understand everyone's concerns."

Although we are currently unable to provide free follow-up treatment like Miaoshou Group.

However, we will purchase high-value insurance for each volunteer to ensure that any problems that arise during the treatment process can be properly resolved.

Furthermore, we will arrange for the most professional medical team to monitor the treatment throughout the process, ensuring everyone's safety.

However, despite Zhang Yue's sincere words, very few people were willing to believe them.

At the end of the day, the number of volunteers recruited fell far short of expectations.

Back at the company, Zhang Yue called another team meeting, and the atmosphere was somewhat tense.

One researcher couldn't help but say, "Mr. Zhang, why don't we give up? Miaoshou Group is too powerful; we simply can't compete with them."

Zhang Yue slammed his hand on the table and said firmly, "No! We can't give up so easily."

We've put so much effort into developing this drug and treatment to help patients with uremia.

We cannot back down because of a little difficulty.

At this moment, Zhan Susu suddenly said, "I have an idea."

We can contact some charities and public welfare organizations to help us with publicity and recruit volunteers.

These institutions have a certain level of credibility among patients and their families, so they might be able to help.

Zhang Yue's eyes lit up: "That's a great idea!"
Immediately contact relevant charities and public welfare organizations to introduce our project and seek their support.

After much effort, the team finally made contact with several influential charities and public welfare organizations.

They were moved by Zhang Yue's team's sincerity and research results, and decided to help with publicity and recruit volunteers.

With the help of charities and public welfare organizations, the recruitment work gradually improved.

More and more patients and their families are beginning to learn about Guoyue Group's projects and have expressed their willingness to become volunteers.

While signing the consent form, a volunteer said to Zhang Yue, "Mr. Zhang, the reason I chose you is because I have seen your perseverance and hard work."

I believe you genuinely want to do something for uremia patients, and I hope I can be a part of this great project.

Zhang Yue held the volunteer's hand tightly and said with emotion, "Thank you for your trust. We will definitely not let you down."

As the number of volunteers gradually increased, the clinical trial was finally able to proceed smoothly.

Looking at the busy figures in the laboratory, Zhang Yue felt a surge of hope.

The atmosphere in the conference room at the headquarters of Miaoshou Group was so heavy it seemed like water could drip from it.

Group Chairman Lin Miaoshou sat in the main seat, his face terribly grim. He slammed his hand on the table and roared:
"Those people from Guoyue Group have actually made progress in the treatment of uremia and have even recruited a lot of volunteers. This is simply a slap in the face to us!"

"Our Miaoshou Group has been a prominent player in the medical field for so many years, how can we let them steal our thunder so easily?"

The marketing manager cautiously asked, "Chairman Lin, what should we do next?"
Public opinion seems to be in their favor now.

A ruthless glint flashed in Lin Miaoshou's eyes: "Hmph, if they can do publicity, so can we."

They arranged for people to spread rumors online and in the media, claiming that Guoyue Group had no ability to treat uremia.

They recruit volunteers to conduct human experiments on patients, completely disregarding the patients' lives.

The head of the publicity department hesitated, "Chairman Lin, isn't this going too far? What if it gets found out..."

Lin Miaoshou interrupted him impatiently: "What are you afraid of! As long as we do it discreetly, who will know that it was us?"
Moreover, even if they find out, so what? With so many connections and resources from Miaoshou Group over the years, are we afraid of not being able to handle a small Guoyue Group?

"Do it right now! Make sure they get their reputation ruined!"

Soon, a large number of negative comments about Guoyue Group began to appear online. Some netizens who were unaware of the facts followed suit and made accusations.

"Guoyue Group has gone too far! They actually used uremia patients for human experiments. This is simply disregarding human life!"

"Exactly, they simply don't have the capability, yet they dare to conduct clinical trials. Isn't that playing with patients' lives?"

At the same time, some media outlets also began to follow suit with reports, each with a more sensational headline than the last.

"Guoyue Group's Clinical Trial for Uremia: Salvation or a Trap?"

Shocking! The astonishing secret hidden behind Guoyue Group's recruitment of volunteers!

These negative reports spread rapidly, causing a huge uproar.

Patients and their families who were initially willing to become volunteers began to waver.

A family member of a volunteer who had already signed the consent form anxiously approached Zhang Yue and angrily said:

"Mr. Zhang, what exactly is going on with you? People online are saying that you are using patients for human experiments and that you don't care about our lives at all."

We can't entrust the lives of our loved ones to an unreliable corporation like yours!

Zhang Yue explained anxiously and sincerely, "Please don't worry, this is all a smear campaign by Miaoshou Group against us."

Our Guoyue Group has always genuinely wanted to do something for uremia patients.

Our research and development process strictly adheres to scientific and ethical standards, and there is absolutely no situation where patients are used for human experimentation.

The volunteers' families, however, wouldn't listen: "Stop trying to argue. The things said online are all very plausible. How can we trust you?"
We are withdrawing from the clinical trial.

Scenes like this are playing out in various places, plunging previously successful clinical trials into an unprecedented crisis.

The recruited volunteers all requested to withdraw, and no one dared to sign up as a new volunteer.

Looking at the deserted laboratory, Zhang Yue was extremely anxious.

He called another meeting with the team, and the atmosphere in the meeting room was so oppressive that it was hard to breathe.

One researcher said helplessly, "Mr. Zhang, public opinion is really against us now."

Many patients and their families don't trust us, making it impossible for the clinical trials to continue.

Zhang Yue frowned, pondered for a moment, and then said, "We cannot sit idly by and wait for our doom."

Therefore, we immediately held a press conference to clarify the facts to the media and the public.

We will disclose our research and development process, safety measures, and other details so that everyone can understand the truth.

The public relations manager said worriedly, "Mr. Zhang, public opinion is now overwhelmingly against us."

"If we hold a press conference, and Miaoshou Group sends people to cause trouble again, or the media doesn't cooperate, that would be a real problem."

Zhang Yue said firmly, "No matter how difficult it is, we must give it a try."

If we don't stand up and clarify, we will never be able to get rid of these unfounded accusations.

"Prepare a press conference immediately; I want to personally explain the situation to everyone."

Soon, preparations for the press conference were complete.

Zhang Yue stood on the stage, his expression serious and resolute. He took a deep breath and said:
"Dear friends from the media, I am holding this press conference today to clarify some false statements about our Guoyue Group that have recently been circulating online."

Our Guoyue Group's research and development of drugs and therapies for treating uremia have undergone rigorous scientific research and ethical review.

Our R&D team consists of top experts, and the entire R&D process adheres to the highest scientific standards and ethical guidelines.

We recruit volunteers for clinical trials to bring new hope to uremia patients, and absolutely not to use patients as human experiments…

However, just as Zhang Yue was speaking enthusiastically, someone in the audience suddenly stood up and shouted:
"You make it sound so nice, but what evidence do you have to prove that you're not using patients for human experiments?"

So many people online say you guys are unreliable, how do you explain that?

This person was sent by the Miaoshou Group to cause trouble.

Suddenly, the audience began to stir, and some media outlets started asking questions, causing the situation to briefly spiral out of control.

Zhang Yue remained calm and said, "Please be quiet."

We have complete research and development data and experimental data to prove our innocence.

Furthermore, we have purchased high-value insurance for each volunteer and arranged for the most professional medical team to provide full-process monitoring and treatment. All of these measures are to ensure the safety and rights of the volunteers.

As for the comments online, it's clear that someone is maliciously smearing our Guoyue Group.

At this moment, a reporter stood up and asked, "Mr. Zhang, you said someone is maliciously smearing you. Do you have any evidence?"

Zhang Yue took a deep breath and said, "Although we don't have conclusive evidence yet, we believe the truth will eventually come out."

Our Guoyue Group will actively cooperate with the relevant departments' investigation. At the same time, we hope that the media and the public can view this matter rationally and not be misled by false information.

After the press conference, although Zhang Yue tried his best to clarify some facts, public opinion did not immediately change.

Miaoshou Group's smear campaign continues, and Guoyue Group's clinical trials remain fraught with crisis.

Zhang Yue returned to his office and sat wearily in a chair.

Zhan Susu walked in and comforted her, "Don't be too anxious. We've already taken the first step in clarifying things. As long as we keep going, people will eventually believe us."

Zhang Yue raised his head, his eyes shining with determination: "You're right, we can't give up."

We must continue to gather evidence to prove our innocence, and at the same time, expedite the clinical trial process to respond to those doubts and smears with tangible results. (End of Chapter)